Politics Dominate AIDS Conference in Montreal

MONTREAL—A major AIDS conference held here last month left top scientists complaining that the sheer number of attendees, along with the noise they generated, prevented the scientists from exchanging ideas. Scientists present at the vast gathering—11,638 registrants from 87 countries, buzzed by 1,320 media people from 47 countries—say they were overwhelmed by the army of social workers and public health officials on the scene. Corridor talk of macrophages and CD-4 receptors

Written byAnthony Liversidge
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

MONTREAL—A major AIDS conference held here last month left top scientists complaining that the sheer number of attendees, along with the noise they generated, prevented the scientists from exchanging ideas.

Scientists present at the vast gathering—11,638 registrants from 87 countries, buzzed by 1,320 media people from 47 countries—say they were overwhelmed by the army of social workers and public health officials on the scene. Corridor talk of macrophages and CD-4 receptors was forced to compete with placard-waving AIDS activists. Protesters disrupted plenary sessions with speeches, demonstrations, and heckling.

One leading AIDS scientist attending the conference, Robert C. Gab of the National Cancer Institute, suggested afterward that the size of the event overwhelmed scientific discourse. According to Gallo, scientists may refuse to attend future AIDS conferences if the problem is not solved. “We need meetings that are smaller, so we [scientists] can find each other, and interact better,” says Gallo. “The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies